Imvax
Imvax is a biotechnology firm that develops and commercializes novel vaccines and immunotherapy for the treatment of malignant gliomas and cancer.
Business Model:
Revenue: $0
Employees: 11-50
Industries / Tags:
Detailed Imvax Information
Geographic Data
Address: 601 Walnut Street
City: Philadelphia
State: PA
Zip: 19106
Country: US
Financial Info
Stage:
series c
Raised Last:
$112M
Raised Total:$151M
Social
Metrics
5,216,139Website Global Rank
1,755Website Monthly Traffic
Twitter Followers
Description
Imvax is a biotechnology firm that develops and commercializes novel vaccines and immunotherapy for the treatment of malignant gliomas and cancer.
Contact Phone:
+12679004110
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2020 | Series C | $0 |
HP WILD HOLDING AG Invus Magnetar Capital TLP Investment Partners Ziff Capital Partners HP WILD HOLDING AG Invus Magnetar Capital TLP Investment Partners Ziff Capital Partners |
5/2019 | Series B | $24.8M | 4/2017 | Series A | $14.7M | 6/2017 | Series A | $14.7M | 9/2019 | Series B | 3 | $40M |
WILD Group Management Magnetar Capital Ziff Capital Partners WILD Group Management Magnetar Capital Ziff Capital Partners |
7/2020 | Series C | 5 | $112M |
Invus Magnetar Capital TLP Investment Partners HP WILD HOLDING AG Invus Magnetar Capital TLP Investment Partners Ziff Capital Partners |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
